BiologicAggregateSizeQualityChecker

Biologic Aggregate Size Quality Checker — Control of Aggregation and Particle Size of Biologics

ℹ️  Utility checks critical quality parameters of biological products:
   • HMW Aggregates (High Molecular Weight): ≤1.0%
   • Main Peak (Monomer): ≥98.0%
   • Particle Size (Z-Average): <15.0 nm (for mAb)
   • Polydispersity Index (PDI): <0.2

⚠️  CRITICAL: High aggregate level (>1.0%) → immunogenicity risk (ADA)!
   Increase in particle size and PDI indicates denaturation or formulation instability.

Usage:
 BiologicAggregateSizeQualityChecker.exe                            → demo mode (console output)
 BiologicAggregateSizeQualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,HmwAggregatesPercent,LmwFragmentsPercent,MainPeakPercent,ZAverageSizeNm,PolydispersityIndex

Example:
 BIO-AGG-2026-001,0.5,0.8,98.7,10.5,0.12

— WHY IS THIS NEEDED?
For therapeutic proteins (monoclonal antibodies, recombinant enzymes), aggregation is a Critical Quality Attribute (CQA).
• Aggregates can trigger unwanted immune responses in patients (formation of anti-drug antibodies, ADA).
• SEC-HPLC (Size Exclusion Chromatography) and DLS (Dynamic Light Scattering) are standards for size and aggregation control.
• USP <1053> and ICH Q6B regulate methods for characterization of biotechnological products.
• Control is necessary at all stages: from formulation development to batch release.

⚠️  CRITICAL:
• HMW Aggregates must be minimal. Even small changes (by 0.1-0.2%) can be significant.
• PDI < 0.2 indicates that the sample is monodisperse (homogeneous in size).
• Growth of Z-Average size beyond the native protein value (e.g., >12-13 nm for IgG) signals onset of oligomerization.
• Storage conditions (temperature, shaking) strongly affect aggregation.

Key features:
• Comprehensive assessment of aggregation (SEC) and size (DLS).
• Immunogenic risk control via HMW limits.
• Support for analytical instrument data for biopharma.

Critical parameters:
• HMW Aggregates: <= 1.0%
• Main Peak (Monomer): >= 98.0%
• Z-Average Size: < 15.0 nm
• PDI: < 0.2

💡 Usage tips:
1. Use filtered buffers to exclude dust during DLS measurements.
2. Perform SEC-HPLC measurements at controlled column temperature.
3. Compare results with the Reference Standard of the specific molecule.
4. For viscous products, account for concentration effects on size (interaction effects).
5. Regularly calibrate instruments using standard proteins (BSA, Ovalbumin) or latex spheres.

⚠️ Note: Aggregation can be reversible (weak bonds) or irreversible (covalent cross-links). This utility assesses the total content of enlarged particles, regardless of bond nature, which is important for overall safety.